Literature DB >> 9420072

Formation of intracerebral cavernous malformations after radiation treatment for central nervous system neoplasia in children.

J J Larson1, W S Ball, K E Bove, K R Crone, J M Tew.   

Abstract

OBJECT: Radiation is a common treatment modality for pediatric brain tumors. The authors present a retrospective review of six children who developed cerebral cavernous malformations after they underwent radiation treatment for central nervous system (CNS) neoplasia and propose two possible models to explain the formation of cavernous malformations.
METHODS: Three boys, aged 13, 9, and 17 years, suffered intracerebral hemorrhages from cerebral cavernous malformations 87, 94, and 120 months, respectively, after they received whole-brain radiation therapy (WBRT) for acute lymphocytic leukemia. A 10-year-old girl and a 19-year-old man developed temporal lobe cavernous malformations 46 and 48 months, respectively, after they received radiation therapy for posterior fossa astrocytomas. A 12-year-old girl developed a temporal lobe cavernous malformation 45 months after WBRT was administered for a medulloblastoma. In all of these cases the cavernous malformation appeared in the irradiated field, was not known to be present prior to radiation therapy, and developed after a latency period following treatment. The incidence of cavernous malformations in these patients suggests that children who undergo radiation therapy of the brain may have an increased risk of hemorrhage.
CONCLUSIONS: Two possible models may explain the formation of cavernous malformations following brain radiation in these patients. First, the cavernous malformations may form de novo in response to the radiation. Second, the cavernous malformations may have been present, but radiographically occult, at the time of radiation therapy and may have hemorrhaged in response to the radiation. The authors conclude that cavernous malformations may develop after brain radiation and propose a possible mechanism for this formation.

Entities:  

Mesh:

Year:  1998        PMID: 9420072     DOI: 10.3171/jns.1998.88.1.0051

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  31 in total

1.  Rates and characteristics of radiographically detected intracerebral cavernous malformations after cranial radiation therapy in pediatric cancer patients.

Authors:  Erica Gastelum; Katherine Sear; Nancy Hills; Erika Roddy; Dominica Randazzo; Nassim Chettout; Christopher Hess; Jennifer Cotter; Daphne A Haas-Kogan; Heather Fullerton; Sabine Mueller
Journal:  J Child Neurol       Date:  2014-08-13       Impact factor: 1.987

2.  Ultra-high-resolution C-arm flat-detector CT angiography evaluation reveals 3-fold higher association rate for sporadic intracranial cavernous malformations and developmental venous anomalies: a retrospective study in consecutive 58 patients with 60 cavernous malformations.

Authors:  Burak Kocak; Osman Kizilkilic; Buge Oz; Dogu Vuralli Bakkaloglu; Cihan Isler; Naci Kocer; Civan Islak
Journal:  Eur Radiol       Date:  2016-09-21       Impact factor: 5.315

3.  Novel loss of function mutation in KRIT1/CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor.

Authors:  Alexandra Russo; Marie Astrid Neu; Johanna Theruvath; Bettina Kron; Arthur Wingerter; Silla Hey-Koch; Yasemin Tanyildizi; Joerg Faber
Journal:  Childs Nerv Syst       Date:  2017-05-09       Impact factor: 1.475

4.  Neuroimaging findings of the post-treatment effects of radiation and chemotherapy of malignant primary glial neoplasms.

Authors:  M D Mamlouk; J Handwerker; J Ospina; A N Hasso
Journal:  Neuroradiol J       Date:  2013-08-27

5.  Cavernous malformations after cerebral irradiation during childhood: report of nine cases.

Authors:  Raphaël Duhem; Matthieu Vinchon; Pierre Leblond; Gustavo Soto-Ares; Patrick Dhellemmes
Journal:  Childs Nerv Syst       Date:  2005-01-21       Impact factor: 1.475

6.  Management of brainstem cavernous malformations.

Authors:  Tarek Y El Ahmadieh; Salah G Aoun; Bernard R Bendok; H Hunt Batjer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-06

7.  Management of intracranial cavernous malformation in pediatric patients.

Authors:  Jae-Whan Lee; Dong-Seok Kim; Kyu-Won Shim; Jong-Hee Chang; Seung-Kon Huh; Yong-Gou Park; Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2007-09-18       Impact factor: 1.475

8.  Treatment and outcome of children with cerebral cavernomas: a survey on 32 patients.

Authors:  Alessandro Consales; Gianluca Piatelli; Marcello Ravegnani; Marco Pavanello; Pasquale Striano; Maria Luisa Zoli; Valeria Capra; Andrea Rossi; Maria Luisa Garrè; Maria Grazia Calevo; Armando Cama
Journal:  Neurol Sci       Date:  2009-10-16       Impact factor: 3.307

9.  Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype.

Authors:  T A Petersen; L A Morrison; R M Schrader; B L Hart
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-15       Impact factor: 3.825

10.  The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.

Authors:  Kevin J Whitehead; Aubrey C Chan; Sutip Navankasattusas; Wonshill Koh; Nyall R London; Jing Ling; Anne H Mayo; Stavros G Drakos; Christopher A Jones; Weiquan Zhu; Douglas A Marchuk; George E Davis; Dean Y Li
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.